Changes in telomere length are associated with degenerative diseases and cancer. Oxidative stress and DNA damage have been linked to both positive and negative alterations in telomere length and integrity. Here we examined how the common oxidative lesion 8-oxo-7,8-dihydro-2′-deoxyguanine (8-oxoG) regulates telomere elongation by human telomerase. When 8-oxoG is present in the dNTP pool as 8-oxodGTP, telomerase utilization of the oxidized nucleotide during telomere extension is mutagenic and terminates further elongation. Depletion of MTH1, the enzyme that removes oxidized dNTPs, increases telomere dysfunction and cell death in telomerase-positive cancer cells with shortened telomeres. In contrast, a preexisting 8-oxoG within the telomeric DNA sequence promotes telomerase activity by destabilizing the G-quadruplex DNA structure. We show that the mechanism by which 8-oxoG arises in telomeres, either by insertion of oxidized nucleotides or by direct reaction with free radicals, dictates whether telomerase is inhibited or stimulated and thereby mediates the biological outcome.
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Jaskelioff, M. et al. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 469, 102–106 (2011).
Armanios, M. & Blackburn, E.H. The telomere syndromes. Nat. Rev. Genet. 13, 693–704 (2012).
Greider, C.W. & Blackburn, E.H. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337, 331–337 (1989).
Hockemeyer, D. & Collins, K. Control of telomerase action at human telomeres. Nat. Struct. Mol. Biol. 22, 848–852 (2015).
Kim, N.W. et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011–2015 (1994).
von Zglinicki, T. Oxidative stress shortens telomeres. Trends Biochem. Sci. 27, 339–344 (2002).
Jurk, D. et al. Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat. Commun. 2, 4172 (2014).
Lonkar, P. & Dedon, P.C. Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates. Int. J. Cancer 128, 1999–2009 (2011).
Poljšak, B. & Fink, R. The protective role of antioxidants in the defence against ROS/RNS-mediated environmental pollution. Oxid. Med. Cell. Longev. 2014, 671539 (2014).
Wang, Z. et al. Characterization of oxidative guanine damage and repair in mammalian telomeres. PLoS Genet. 6, e1000951 (2010).
Kamiya, H. & Kasai, H. Formation of 2-hydroxydeoxyadenosine triphosphate, an oxidatively damaged nucleotide, and its incorporation by DNA polymerases: steady-state kinetics of the incorporation. J. Biol. Chem. 270, 19446–19450 (1995).
Freudenthal, B.D. et al. Uncovering the polymerase-induced cytotoxicity of an oxidized nucleotide. Nature 517, 635–639 (2015).
Tsuzuki, T. et al. Spontaneous tumorigenesis in mice defective in the MTH1 gene encoding 8-oxo-dGTPase. Proc. Natl. Acad. Sci. USA 98, 11456–11461 (2001).
Gad, H. et al. MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool. Nature 508, 215–221 (2014).
Sakumi, K. et al. Cloning and expression of cDNA for a human enzyme that hydrolyzes 8-oxo-dGTP, a mutagenic substrate for DNA synthesis. J. Biol. Chem. 268, 23524–23530 (1993).
Speina, E. et al. Contribution of hMTH1 to the maintenance of 8-oxoguanine levels in lung DNA of non-small-cell lung cancer patients. J. Natl. Cancer Inst. 97, 384–395 (2005).
Patel, A. et al. MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways. Oncogene 34, 2586–2596 (2015).
Liou, G.Y. & Storz, P. Reactive oxygen species in cancer. Free Radic. Res. 44, 479–496 (2010).
Szatrowski, T.P. & Nathan, C.F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 51, 794–798 (1991).
Wallace, S.S. Base excision repair: a critical player in many games. DNA Repair (Amst.) 19, 14–26 (2014).
Zhou, J., Liu, M., Fleming, A.M., Burrows, C.J. & Wallace, S.S. Neil3 and NEIL1 DNA glycosylases remove oxidative damages from quadruplex DNA and exhibit preferences for lesions in the telomeric sequence context. J. Biol. Chem. 288, 27263–27272 (2013).
Askree, S.H. et al. A genome-wide screen for Saccharomyces cerevisiae deletion mutants that affect telomere length. Proc. Natl. Acad. Sci. USA 101, 8658–8663 (2004).
Lu, J. & Liu, Y. Deletion of Ogg1 DNA glycosylase results in telomere base damage and length alteration in yeast. EMBO J 29, 398–409 (2010).
Schmidt, J.C. & Cech, T.R. Human telomerase: biogenesis, trafficking, recruitment, and activation. Genes Dev. 29, 1095–1105 (2015).
Xi, L. & Cech, T.R. Inventory of telomerase components in human cells reveals multiple subpopulations of hTR and hTERT. Nucleic Acids Res. 42, 8565–8577 (2014).
Traut, T.W. Physiological concentrations of purines and pyrimidines. Mol. Cell. Biochem. 140, 1–22 (1994).
Sohl, C.D., Ray, S. & Sweasy, J.B. Pools and Pols: mechanism of a mutator phenotype. Proc. Natl. Acad. Sci. USA 112, 5864–5865 (2015).
Katafuchi, A. & Nohmi, T. DNA polymerases involved in the incorporation of oxidized nucleotides into DNA: their efficiency and template base preference. Mutat. Res. 703, 24–31 (2010).
Hsu, G.W., Ober, M., Carell, T. & Beese, L.S. Error-prone replication of oxidatively damaged DNA by a high-fidelity DNA polymerase. Nature 431, 217–221 (2004).
Bertram, J.G., Oertell, K., Petruska, J. & Goodman, M.F. DNA polymerase fidelity: comparing direct competition of right and wrong dNTP substrates with steady state and pre-steady state kinetics. Biochemistry 49, 20–28 (2010).
Tomlinson, C.G. et al. Two-step mechanism involving active-site conformational changes regulates human telomerase DNA binding. Biochem. J. 465, 347–357 (2015).
Rai, P. et al. Continuous elimination of oxidized nucleotides is necessary to prevent rapid onset of cellular senescence. Proc. Natl. Acad. Sci. USA 106, 169–174 (2009).
Crabbe, L., Cesare, A.J., Kasuboski, J.M., Fitzpatrick, J.A. & Karlseder, J. Human telomeres are tethered to the nuclear envelope during postmitotic nuclear assembly. Cell Rep. 2, 1521–1529 (2012).
O'Sullivan, R.J. et al. Rapid induction of alternative lengthening of telomeres by depletion of the histone chaperone ASF1. Nat. Struct. Mol. Biol. 21, 167–174 (2014).
Takai, H., Smogorzewska, A. & de Lange, T. DNA damage foci at dysfunctional telomeres. Curr. Biol. 13, 1549–1556 (2003).
Takai, K.K., Hooper, S., Blackwood, S., Gandhi, R. & de Lange, T. In vivo stoichiometry of shelterin components. J. Biol. Chem. 285, 1457–1467 (2010).
Sfeir, A. et al. Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell 138, 90–103 (2009).
Biffi, G., Tannahill, D., McCafferty, J. & Balasubramanian, S. Quantitative visualization of DNA G-quadruplex structures in human cells. Nat. Chem. 5, 182–186 (2013).
Hwang, H. et al. Telomeric overhang length determines structural dynamics and accessibility to telomerase and ALT-associated proteins. Structure 22, 842–853 (2014).
Zahler, A.M., Williamson, J.R., Cech, T.R. & Prescott, D.M. Inhibition of telomerase by G-quartet DNA structures. Nature 350, 718–720 (1991).
Cookson, J.C. et al. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents. Mol. Pharmacol. 68, 1551–1558 (2005).
Meyer, P.R., Matsuura, S.E., So, A.G. & Scott, W.A. Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism. Proc. Natl. Acad. Sci. USA 95, 13471–13476 (1998).
Vorlícková, M., Tomasko, M., Sagi, A.J., Bednarova, K. & Sagi, J. 8-oxoguanine in a quadruplex of the human telomere DNA sequence. FEBS J. 279, 29–39 (2012).
Tippana, R., Xiao, W. & Myong, S. G-quadruplex conformation and dynamics are determined by loop length and sequence. Nucleic Acids Res. 42, 8106–8114 (2014).
Oikawa, S., Tada-Oikawa, S. & Kawanishi, S. Site-specific DNA damage at the GGG sequence by UVA involves acceleration of telomere shortening. Biochemistry 40, 4763–4768 (2001).
Hukezalie, K.R., Thumati, N.R., Côté, H.C. & Wong, J.M. In vitro and ex vivo inhibition of human telomerase by anti-HIV nucleoside reverse transcriptase inhibitors (NRTIs) but not by non-NRTIs. PLoS One 7, e47505 (2012).
Oulton, R. & Harrington, L. A human telomerase-associated nuclease. Mol. Biol. Cell 15, 3244–3256 (2004).
Huard, S. & Autexier, C. Human telomerase catalyzes nucleolytic primer cleavage. Nucleic Acids Res. 32, 2171–2180 (2004).
Pursell, Z.F., McDonald, J.T., Mathews, C.K. & Kunkel, T.A. Trace amounts of 8-oxo-dGTP in mitochondrial dNTP pools reduce DNA polymerase gamma replication fidelity. Nucleic Acids Res. 36, 2174–2181 (2008).
Kunkel, T.A. DNA replication fidelity. J. Biol. Chem. 279, 16895–16898 (2004).
Kreiter, M., Irion, V., Ward, J. & Morin, G. The fidelity of human telomerase. Nucleic Acids Symp. Ser. 137–139 (1995).
Bisoffi, M., Heaphy, C.M. & Griffith, J.K. Telomeres: prognostic markers for solid tumors. Int. J. Cancer 119, 2255–2260 (2006).
Kettle, J.G. et al. Potent and selective inhibitors of MTH1 probe its role in cancer cell survival. J. Med. Chem. 59, 2346–2361 (2016).
Zhang, X., Mar, V., Zhou, W., Harrington, L. & Robinson, M.O. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev. 13, 2388–2399 (1999).
Mender, I., Gryaznov, S., Dikmen, Z.G., Wright, W.E. & Shay, J.W. Induction of telomere dysfunction mediated by the telomerase substrate precursor 6-thio-2′-deoxyguanosine. Cancer Discov. 5, 82–95 (2015).
Rhee, D.B., Ghosh, A., Lu, J., Bohr, V.A. & Liu, Y. Factors that influence telomeric oxidative base damage and repair by DNA glycosylase OGG1. DNA Repair (Amst) 10, 34–44 (2011).
Giribaldi, M.G., Munoz, A., Halvorsen, K., Patel, A. & Rai, P. MTH1 expression is required for effective transformation by oncogenic HRAS. Oncotarget 6, 11519–11529 (2015).
Piskounova, E. et al. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature 527, 186–191 (2015).
Fouquerel, E. et al. ARTD1/PARP1 negatively regulates glycolysis by inhibiting hexokinase 1 independent of NAD+ depletion. Cell Rep. 8, 1819–1831 (2014).
Latrick, C.M. & Cech, T.R. POT1-TPP1 enhances telomerase processivity by slowing primer dissociation and aiding translocation. EMBO J 29, 924–933 (2010).
Pham, H.H. et al. Cooperative hybridization of γPNA miniprobes to a repeating sequence motif and application to telomere analysis. Org. Biomol. Chem. 12, 7345–7354 (2014).
Ohno, M., Oka, S. & Nakabeppu, Y. Quantitative analysis of oxidized guanine, 8-oxoguanine, in mitochondrial DNA by immunofluorescence method. Methods Mol. Biol. 554, 199–212 (2009).
Parikh, D., Fouquerel, E., Murphy, C.T., Wang, H. & Opresko, P.L. Telomeres are partly shielded from ultraviolet-induced damage and proficient for nucleotide excision repair of photoproducts. Nat. Commun. 6, 8214 (2015).
Herbert, B.S., Shay, J.W. & Wright, W.E. Analysis of telomeres and telomerase. Curr. Protoc. Cell Biol. 20, 18.16 (2003).
We thank S. Watkins and C. St. Croix (University of Pittsburgh Center for Biological Imaging) for assistance with fluorescence imaging, S. Uttam for help with statistical analyses, T. Moiseeva for assistance with the annexin V and propidium iodide FACS assay and R. O'Sullivan and B. Van Houten for critical reading of the manuscript. We also thank T. Cech and A. Zaug (University of Colorado) for reagents and assistance with the telomerase assays and R. O'Sullivan (University of Pittsburgh) for generously providing the HeLa VST and HeLa LT cell lines. This work was supported by NIH grants R01ES022944, R21AG045545 and R21ES025606 (to P.L.O.), American Cancer Society RSG-12-066-01-DMC and NIH 1DP2GM105453 (to T.L., G.K. and S.M.), NIH grant R00ES024431 (to B.D.F.), and NIH grant CA148629 and the Abraham A. Mitchell Distinguished Investigator fund (to R.W.S.). This project used the UPCI CTIF and CF, which are supported in part by award P30CA047904.
R.W.S. is a scientific consultant for Trevigen, Inc. The other authors declare no competing financial interests.
Integrated supplementary information
(a) Telomerase reactions were conducted using (TTAGGG)3 substrate (oligo #1 in Supplementary Table 1) and contained high dNTPs (lanes 1 - 4) or cellular dNTPs (lanes 5 - 8) and 0.3 μM 32P-α-dGTP. Natural dGTP and 8-oxodGTP were mixed at 1:0, 1:1, and 0:1 ratios to maintain a total concentration of 500 μM or 5.2 μM of unlabeled guanine nucleotide. Lanes marked with 0* contained 0.3 μM 32P-α-dGTP, and lacked unlabeled dGTP. Products were separated on polyacrylamide denaturing gels. The LC was a 32P end-labeled 18-mer oligonucleotide. Numbers with plus sign indicate number of telomeric repeats added. (b) Products were quantitated and normalized to the LC, and used to calculate processivity (top graph) and relative activity (bottom graph). Bars represent the mean and s.d. from three independent reactions. Asterisks, ** p < 0.01, *** p < 0.001 based on two-tailed Student’s t test.
Supplementary Figure 2 Elongation termination after 8-oxodGTP is not due to inhibition of telomerase translocation.
Telomerase reactions were conducted using (GGTTAG)3 (oligonucleotide 2 in Supplementary Table 1), and contained cellular dNTPs (37 μM dTTP, 24 μM dATP, 29 μM dCTP, 5.2 μM dGTP) and 0.3 μM 32P-α-dTTP. dGTP and 8-oxodGTP were mixed at 1:0, 1:1, and 0:1 ratios to maintain a total concentration of 5.2 μM of unlabeled guanine nucleotide. Products were separated on polyacrylamide denaturing gels. The LC was a 32P end-labeled 18-mer oligonucleotide. Numbers with plus sign indicate number of repeats added.
Supplementary Figure 3 MTH1 depletion generates DNA damage in HeLa cell lines with very short or long telomeres.
(a) Telomere lengths were confirmed by Southern blotting of telomeric restrictions fragments. The DNA ladder is shown. UD indicates undigested genomic DNA and D indicates digested genomic DNA. (b) Cell lysate was immuno-stained for catalase and SOD expression prior to lentiviral infection. (c) Cells were immuno-stained with an 8-oxoG antibody (green) three days after infection with lentivirus expressing a non-targeting shRNA (scr) or two different shRNAs targeting MTH1 (sh4 or sh5). Nuclei are indicated by DAPI staining (blue). Exposure times and image settings were equivalent for the sh4 and sh5, compared to the scr control. (d) Cells were stained for telomeric DNA by FISH (green) and immuno-stained with a TRF2 antibody (red) three days after lentiviral infection. Nuclei are indicated by DAPI. (e) The average number of TIFs per cell nuclei was calculated after three days post infection with lentivirus. Bars represent the mean ± sd from 3 independent experiments (100 – 150 cells per condition). * p<0.01 based on One-way ANOVA with Tukey’s honest significance difference. (f) Prolong cell culturing partly restores MTH1 expression. Cell lysate was immuno-stained for MTH1 following 138 days after lentiviral infection, which corresponds to population doubling (PD) numbers or HeLa VST of 151 (scr and sh5) or 139 (sh4) and for HeLa LT of 140 (scr and sh5) and 135 (sh4).
(a and b) Apoptosis was measured by annexin V staining and flow cytometry in HeLa VST or HeLa LT 6 (a) and 9 (b) days after infection with lentivirus expressing a non-targeting shRNA (scr) or different shRNAs against MTH1 (sh4 and sh5). Numbers above red box indicate total annexin V positive cells. Bar graphs show the mean ± s.d. of 4 replicates. ****p<0.0001, by two-tailed Student’s t test. By 9 days post-infection no significant increase in apoptosis is detected in either cell line. (c) MTH1 depletion triggers minimal apoptosis in BJ-hTERT and BJ fibroblasts compared to controls, 3 days after lentivirus infection, compared to controls, as measured by annexin V by flow cytometry.
(a) Immunoblot with antibodies against MTH1 or actin. The percent MTH1 expression relative to the controls are shown. (b) Cells were immuno-stained with an 8oxoG antibody (green) 3 days after infection with lentivirus expressing a non-targeting shRNA (scr) or two different shRNAs targeting MTH1 (sh4 or sh5). Nuclei are indicated by DAPI staining (blue). Exposure times and image settings were equivalent for the sh4 and sh5, compared to the scr control. (c) BJhTERT and BJ cells were fixed 3 days after lentiviral infection and stained for SA-beta-gal activity. The percentage of positive cells is indicated on the bar graph. (d) Whole cell lysates (10μg) were immunoblotted with anti-p53 and anti-actin antibody as a loading control 3 days after lentiviral infection. (e) MTH1 knock down impairs BJ-hTERT proliferation as compared to BJ fibroblasts. DIC images were captured 12 days following lentiviral infection with a 10x objective.
(a) Telomerase reactions were conducted using primers containing three TTAGGG repeats terminating in GGG, GGGoxoG, or GGGToxoG (Supplemental Table 1, oligos #3, 9 and 10). Reactions contained cellular dNTP concentrations and 0.3 μM 32P-α-dGTP. Products were separated on denaturing gels. The LC was a 32P end labeled 36-mer oligonucleotide. Numbers with plus sign indicate number of added repeats. (b) and (c), Products were normalized to the LC, and used to calculate processivity (b) and relative activity (c). Bars represent the mean ± s.d. from three independent reactions. (d) Telomerase reactions contained high dNTPs (lane 1) or 2.9 μM dGTP (lanes 2-4) and 0.3 μM 32P-α-dGTP. Products were separated on polyacrylamide denaturing gels. The LC was 32P end-labeled 18-mer oligonucleotide. Bands representing addition (+) or subtraction (-) of telomeric repeats are indicated. Product size and corresponding sequence are shown, red = radiolabeled G insertion. (e) Products were quantitated and normalized to the LC, and used to calculate relative activity. Bars represent the mean and s.d. from three independent reactions.
(a) Telomerase preparations lack contaminating exonuclease activity. 8-oxoG substitutions in the 4R substrate are indicated in red “Go” (oligos 6-8 in Supplementary Table 1). Reactions (20 μl) contained 19.5 pmol primer and 0.5 pmol 32P end-labeled primer for a final total concentration of 1 μM in 1x human telomere buffer. The dNTPs were omitted. Reactions were initiated by adding 6 μl telomerase extract and incubated for 60 min at 30oC, and then run on polyacrylamide denaturing gels. (b) Telomerase reactions were conducted using primers containing three or four TTAGGG repeats, with a 3’ terminal G or 8-oxoG (oligos 3, 4, 6 and 7 Supplementary Table 1). Reactions contained high dNTPs (lane 1) or 2.9 μM dGTP (lanes 2-5) and 0.3 μM 32P-α-dGTP. Products were separated on polyacrylamide denaturing gels. The LC was 32P end-labeled 18-mer oligonucleotide. Bands representing addition (+) or subtraction (-) of telomeric repeats are indicated for 3 repeat (left) and 4 repeat (right) substrate. Product size and corresponding sequence are shown, red = radiolabeled G insertion. (c) Products were quantitated and normalized to the LC, and used to calculate relative activity. Bars represent the mean and s.d. from three independent reactions. Asterisks, ** p < 0.01, *** p < 0.001 base on two-tailed Student’s t test.
About this article
Cite this article
Fouquerel, E., Lormand, J., Bose, A. et al. Oxidative guanine base damage regulates human telomerase activity. Nat Struct Mol Biol 23, 1092–1100 (2016). https://doi.org/10.1038/nsmb.3319
Pharmacology & Therapeutics (2021)
Redox Biology (2021)
Biochimica et Biophysica Acta (BBA) - General Subjects (2021)
International Journal of Molecular Sciences (2021)
External environmental agents influence telomere length and telomerase activity by modulating internal cellular processes: Implications in human aging
Environmental Toxicology and Pharmacology (2021)